Deepika Jalota - 13 Aug 2024 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Development Officer
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
13 Aug 2024
Transactions value $
$0
Form type
4
Filing time
03 Oct 2024, 16:50:25 UTC
Previous filing
22 Jan 2024
Next filing
12 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -22,674 -100% 0 13 Aug 2024 Common Stock 22,674 $28.33 Direct F1, F2
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -68,100 -100% 0 13 Aug 2024 Common Stock 68,100 $16.29 Direct F3, F4
transaction PMVP Employee Stock Option (right to buy) Award +90,774 90,774 13 Aug 2024 Common Stock 90,774 $1.48 Direct F2, F4, F5
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -125,000 -100% 0 13 Aug 2024 Common Stock 125,000 $5.7 Direct F6, F7
transaction PMVP Employee Stock Option (right to buy) Award +125,000 125,000 13 Aug 2024 Common Stock 125,000 $1.49 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
F2 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 22,674 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 22,674 shares, having an exercise price of $1.48 per share.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
F4 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 68,100 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 68,100 shares, having an exercise price of $1.48 per share.
F5 One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
F6 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.
F7 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 125,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 125,000 shares, having an exercise price of $1.48 per share.
F8 One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.